Abstract
Chronic kidney disease (CKD) in heart failure (HF) increases the risk of hyperkalaemia (HK), limiting angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use. Patiromer is a sodium-free, non-absorbed potassium binder approved for HK treatment. We retrospectively evaluated patiromer's long-term safety and efficacy in HF patients from AMETHYST-DN. Patients with Type 2 diabetes, CKD, and HK [baseline serum potassium >5.0-5.5 mmol/L (mild) or >5.5-<6.0 mmol/L (moderate)], with or without HF (New York Heart Association Class I and II, by investigator judgement), on ACE-I/ARB, were randomized to patiromer 8.4-33.6 g to start, divided twice daily. Overall, 105/304 (35%) patients had HF (75%, Class II). Mean (standard deviation) ejection fraction (EF) was 44.9% (8.2) (n = 81) in patients with HF; 26 had EF ≤40%. In HF patients, mean serum potassium decreased by Day 3 through Week 52. At Week 4, estimated mean (95% confidence interval) change in serum potassium was -0.64 mmol/L (-0.72, -0.55) in mild and -0.97 mmol/L (-1.14, -0.80) in moderate HK (both P < 0.0001). Most HF patients with mild (>88%) and moderate (≥73%) HK had normokalaemia at each visit from Weeks 12 to 52. Three HF patients were withdra...Continue Reading
References
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Nov 5, 1997·Journal of General Internal Medicine·M A Perazella, R L Mahnensmith
Sep 2, 1999·The New England Journal of Medicine·B PittJ Wittes
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Jun 24, 2009·Archives of Internal Medicine·Lisa M EinhornJeffrey C Fink
Oct 22, 2009·JAMA : the Journal of the American Medical Association·Nancy M AlbertGregg C Fonarow
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
Jan 7, 2011·European Heart Journal·Bertram PittUNKNOWN PEARL-HF Investigators
Nov 8, 2011·Clinical Cardiology·Gil CherninDonald S Silverberg
Feb 22, 2012·The American Journal of Cardiology·Nishank JainSubhash Banerjee
Jan 17, 2013·The American Journal of Medicine·Ziv HarelChaim M Bell
Jan 30, 2013·BMJ : British Medical Journal·Harikrishna MakaniFranz H Messerli
Aug 27, 2013·International Journal of Clinical Pharmacy·Marianne A KuijvenhovenMirjam Crul
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Nov 22, 2014·The New England Journal of Medicine·Matthew R WeirUNKNOWN OPAL-HK Investigators
Jul 15, 2015·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN AMETHYST-DN Investigators
Aug 26, 2015·Hypertension·Bertram Pitt, George L Bakris
Sep 17, 2015·Kidney International·David A BushinskyGeorge L Bakris
Oct 16, 2015·European Journal of Heart Failure·Bertram PittMatthew R Weir
Nov 21, 2015·Clinical Nephrology·Amanda E HaganMark M Belz
Feb 10, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Lingyun LiJerry Buysse
May 18, 2016·Expert Opinion on Pharmacotherapy·Murray Epstein, Bertram Pitt
May 22, 2016·European Journal of Heart Failure·Piotr PonikowskiUNKNOWN Document Reviewers
May 22, 2016·Circulation·UNKNOWN WRITING COMMITTEE MEMBERSCheryl Westlake
Jun 29, 2016·Kidney International·Matthew R WeirGordon H Williams
Sep 30, 2016·Clinical Journal of the American Society of Nephrology : CJASN·David A BushinskyBertram Pitt
Citations
Mar 14, 2019·Current Opinion in Nephrology and Hypertension·Silvia J LeonNavdeep Tangri
May 28, 2019·European Journal of Heart Failure·Petar M SeferovicAndrew J S Coats
Oct 11, 2019·Current Opinion in Nephrology and Hypertension·Marie Frimodt-MøllerPeter Rossing
Jan 16, 2020·Revista da Associação Médica Brasileira·Renato Watanabe
Jan 24, 2020·Postgraduate Medicine·Csaba P KovesdyBrian C Sauer
Apr 3, 2020·PharmacoEconomics·Julia WidénC Simone Sutherland
Jun 27, 2020·The Cochrane Database of Systematic Reviews·Patrizia NataleGiovanni Fm Strippoli
Mar 7, 2019·European Heart Journal Supplements : Journal of the European Society of Cardiology·Shilpa VijayakumarGeorge L Bakris
Dec 4, 2019·Wiener klinische Wochenschrift·Thomas WeberUNKNOWN Österreichische Gesellschaft für Kinder- und Jugendheilkunde
Dec 5, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maxime CoutrotMatthieu Legrand
Jul 22, 2018·Clinical Drug Investigation·Hannah A Blair
Dec 5, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Angela Yee-Moon Wang
Jan 8, 2020·European Heart Journal Supplements : Journal of the European Society of Cardiology·Patrick RossignolGiuseppe Rosano
May 8, 2020·Cardiovascular Diabetology·Bo LiangNing Gu
Oct 26, 2018·Acta Clinica Belgica·R VanholderE V Nagler
Jun 27, 2019·Herz·I E EmrichM Böhm
May 10, 2020·Internal and Emergency Medicine·Claudia D'AlessandroAdamasco Cupisti
Oct 30, 2020·ESC Heart Failure·Markus S AnkerStephan von Haehling
Nov 2, 2019·Mayo Clinic Proceedings·Biff F Palmer
Nov 9, 2020·Mayo Clinic Proceedings·Biff F PalmerMatthew R Weir
May 28, 2019·Kidney International·Jonatan Barrera-ChimalFrederic Jaisser
Aug 9, 2021·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Steven FishbaneBruce Spinowitz
Aug 28, 2021·European Heart Journal·Theresa A McDonaghUNKNOWN ESC Scientific Document Group
Sep 8, 2021·Frontiers in Medicine·Frank Lizaraso-SotoFrancisco Herrera-Gómez